Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In Glen Oaks
This study has public registry information. It focuses on ADHD and currently lists study information in Germany.
In Mainz
This study was withdrawn in the United States. It is testing Medical Information Device #1 for schizophrenia.
Multiple locations, including CerritosThis study is ongoing. It focuses on bipolarity and currently lists study information in Spain.
In SpainThis study is completed. It focuses on PTSD and currently lists study information in Global.
In Global
This study is completed. It focuses on suicide prevention and currently lists study information in the United States.
In SyracuseThis study is active but not recruiting. It focuses on bipolarity and currently lists study information in China.
In Hong KongThis study has public registry information. It focuses on bipolarity and currently lists study information in Canada.
In TorontoThis study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In BostonThis study is completed. It focuses on schizophrenia and currently lists study information in China.
In ShijiazhuangThis study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In MasonThis study is completed. It focuses on schizophrenia and currently lists study information in Canada.
In OttawaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.